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Sary Sialyl-Tn (STn) is a core region carcinoma-associated carbohydrate determinant expressed on
cancer-associated mucins. Expression of STn has been associated with poor prognosis in colon and ovarian
cancer, independent of other prognostic factors such as tumour grade, stage or histological type. Recent
studies have suggested that STn expression may be an indpendent prognostic variable in gastric cancer. We
have examined 158 patients with gastric cancer using the antibody B723 (Biomira, Edmonton, Alberta,
Canada). Of these, 110 patients (70%) expressed STn. Expression of STn did not correlate with tumour
differentiation or the Ming classification, but expression was noted more frequently in the relatively good
prognosis intestinal type of tumours (12 = 6.9, P = 0.03). Conversely, early-stage cancers showed a significantly
lower frequency of expression than more advanced cases (X2 = 13.75, P = 0.003). In this patient group, STn
expression did not influence survival, and in multivariate regression analysis only tumour stage and Lauren
classification were found to be independent prognostic variables.
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Abnormal glycosylation patterns have been recognised as a
feature of carcinoma-associated mucins (Hakomori, 1985).
Sialyl-Tn (a[2-61-N-acetylgalactosamine, STn) is a core
region carbohydrate antigen of tumour-associated mucin
(Kjeklsen et al., 1988) formed by the premature 2-6 sialation
of N-acetylgalactosamine (Nakasaki et al., 1989). STn ex-
pression has been studd in several tumour types and found
to be of prognostic signnce in colonic carcinoma (Itz-
kowitz et al., 1990). Circulating antigen has also been
detected in gastrointestinal and ovarian malignancies, and
raised levels have also been shown to be associated with a
poor prognosis (Motoo et al., 1991; Kobayashi et al., 1992).
Recent reports have suggested that the expression of STn in
gastnc carcinoma is an independent prognostic feature (Chun
Ma et al., 1993; Werther et al., 1994). In one of the largest
published series, we have examined the effect of STn expres-
sion on prognosis and its relationship with known prognostic
factors.
Materals and methods
Clinical material
Pathological material from 158 patients whose gastric cancer
was considered surgically resectable was examined. Tissue,
which was fixed in formalin and embedded in paraffin, was
collected between 1979 and 1989 with a median follow-up for
the cases studied of 6.9 years. The tumours were classified
into intestinal or diffuse (Lauren, 1965) and expanding or
infiltrating (Ming, 1977). Stage was defined according to the
TNM system (Kennedy, 1970). Survival was known in 139
cases.
Immunohistochemistry
Staining for STn was assessed on 3 pm sections cut from
formalin-fixed, paraffin-embedded tissue. Sections were
incubated for 60 min at room temperature with the antibody
B72.3 (Biomira, Edmonton, Alberta, Canada) raised against
ovine submaxillary mucin, and used at a dilution of 1:100.
Sections were then treated with biotinylated rabbit anti-
mouse immunoglobulin followed by avidin-biotin complex.
Peroxidase activity was demonstrated using diaminobenzidine
solution and nuclei were counterstained with Mayer's
haematoxylin. Negative controls were carried out by sub-
stituting buffer for the primary antibody. All cases with
stained cells were considered as positive. Immunoreactivity
was further characterised as focal (up to 30% of cells
positive), patchy (between 30 and 60% of cells positive) and
extensive (more than 60% cells positive).
Statistical analysis
Relationships between variables were examined using the
chi-squared test. Relapse-free and overall survival were cal-
culated using the method of Kaplan and Meier (Peto et al.,
1977) and differences between curves were analysed by the
log-rank test. Multivariate analysis was by Cox's propor-
tional hazards model (Cox, 1972).
Resuts
STn staining was detected in the cell membrane, luminal
mucus and cytoplasm, but its distribution varied between
tumours. Membrane staining was a prominent feature in
intesinal, well-differentiated tumours (Figure 1), while in
Figwe 1 Intestinal-type adenocarcinoma: STn expression in the
cenl membrane (immunoperoxidase, bar = 80gm).
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4?diffuse signet ring tumours STn staining was predominantly
cytoplasmic (Figure 2). An example of lymphatic invasion by
an STn-positive tumour is illustrated in Figure 3. Of 158
cases studied, 110 (70%) expressed STn. Of these, 51 cases
(46%) showed a focal staining pattern with 15 (14%) and 44
(40%) showing patchy and extensive staining patterns respec-
tively. The clinicopathological features of patients according
to STn staining are shown in Table I. Although expression of
STn did not correlate with tumour differentiation or the
Ming classification, a significantly higher proportion of the
intestinal carcinomas expressed STn (x2 6.9, P = 0.03). Early-
stage cancers showed significantly lower frequencies of STn
expression than more advanced cases (X2 = 13.75, P = 0.003).
Figure 2 Diffuse signet ring adenocarcinoma: STn expression in
the cytoplasm (immunoperoxidase, bar = 50jam).
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Overall survival ofpatients by STn staining is illustrated in
Figure 4. STn expression did not influence survival in this
patient group. In multivariate regression analysis, only
tumour stage and Lauren classification were found to be
independent prognostic variables (Table II).
Discussion
Malignant transformation of epithelial cells is frequently
associated with altered glycosylation of cell membrane
glycoproteins or glycolipids. In the case of 0-linked oligosac-
charides, the premature 2-6 sialation of the Tn antigen
(GalNAc) leads to accumulation of the STn antigen
(Nakasaki et al., 1989). Expression of this carcinoma-
associated antigen in tissue and serum has been shown to be
a prognostic factor in colorectal and ovarian adenocar-
cinomas (Itzkowitz et al., 1990; Kobayashi et al., 1992). It
has been demonstrated that tumour-associated glycoproteins
(Irimura et al., 1987) and sialic acid residues (Dennis et al.,
1982) may be involved in cell-cell or cell-matrix interac-
tions. It has been postulated therefore that the association of
STn expression and poor prognosis may be due to such
interactions in a manner analogous to the interaction
between ELAM-1 and the blood group-related antigens sialyl
Lewis A and sialyl Lewis X. Cells expressing STn might
therefore be expected to have higher metastatic potential, and
this hypothesis is supported by animal data (Bresalier et al.,
1991).
Recent data have suggested that STn expression in gastric
cancer may be unrelated to established pathological charac-
teristics (David et al., 1992) and may indeed be an indepen-
dent prognostic factor (Chun Ma et al., 1993; Werther et al.,
1994). In the present study using the antibody B72.3, we have
demonstrated expression of STn in 110 of 158 cases studied
(70%), an incidence of positivity which is in agreement with
previous reports. As in the study of Chun Ma et al., we
noted a strong correlation between STn positivity and
tumour stage. Conversely, however, we have noted a
significantly higher incidence of STn expression in the
relatively good prognosis intestinal type of tumours (Lauren
classification). STn expression was of no prognostic value
considering the group as a whole, and in a Cox model only
tumour stage and Lauren classification were of independent
prognostic value. Although, using a proportional hazards
model, Chun Ma concluded that STn expression was an
independent prognostic factor (P = 0.0285), tumour size
(significantly higher in STn-positive tumours) was not
Figure 3 Lymphatic permeation
(immunoperoxidase, bar = 50 nAm).
by STn positive tumour
Table I Clinical/pathological features of patients by STn staining
STn -ve STn + ve
Factor (32%) (68%)
Stage
1 1 (2%) 8 (8%) x= 13.75
2 14 (29%) 8 (8%) P=0.003
3 21 (44%) 62 (63%)
4 12 (25%) 21 (21%)
Differentiation
Good 10 (21%) 28 (25%) x2= 5.35
Moderate 10 (21%) 39 (35%) P=0.07
Poor 28 (58%) 43 (39%)
Lauren classification
Intestinal 23 (48%) 74 (69%) x2= 6.9
Diffuse 22 (46%) 27 (25%) P=0.03
Mixed 3 (6%) 6 (6%)
Ming classification
Expanding 22 (48%) 57 (56%) x2= 0.53
Infiltrating 24 (52%) 45 (44%) P=0.46
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Figure 4 Overall survival by STn staining.
Table II Multivariate analysis of prognostic factors for overall
survival
Variable x2 P-value
Stage 17.49 <0.0001
Lauren classification 7.56 0.006
STn staining 0.87 0.3514
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included in the model. Inclusion of this may have influenced
the prognostic value of STn. Although Werther et al. (1994)
conclude that STn expression did not correlate with stage or
differentiation, they do note a higher incidence of STn
positivity in T3 and T4 lesions which may not have reached
statistical significance because of the small numbers involved
in the study.
STn expression may be important in the biology of human
gastric cancer in terms of invasive capacity and metastatic
potential. Conversely, the involvement of related antigens in
cellular immune responses (Singhal, 1991) suggests that it
may also be involved in the host immune response to
tumour. We did not find any potential effect of STn expres-
sion on prognosis to be independent of established factors
such as tumour stage and Lauren classification.
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